References

1. Freudiger U. Krankheiten des exokrinen Pankreas bei der Katze. Berl Munch Tierdrztl Wschr 1989; 102: 37—43.

2. Pandol SJ. Pancreatic physiology and secretory testing. In: Feldman M, Friedman LS, Sleisenger MH (eds.) Gastrointestinal and liver dis­ease.

3. Fyfe JC. Feline intrinsic factor (IF) is pancreatic in origin and medi­ates ileal cobalamin (CBL) absorption. J Vet Intern Med 1993; 7: 133 (abstract).

4. Carriere F, Laugier R, Barrowman JA et al. Gastric and pancreatic lipase levels during a test meal in dogs. Scand J Gastroenterol 1993; 28: 443-454.

5. Steer ML, Perides G. Pathogenesis: how does acute pancreatitis de­velop. In: Dominguez-Munoz JE (ed.) Clinical pancreatology for practic­ing gastroenterologists and surgeons. Malden, Blackwell Publishing, 2005; 10-26.

6. Sahin-Toth M. Biochemical models of hereditary pancreatitis. Endo­crinol Metab Clin North Am 2006; 35: 303-312.

7. Bishop MA, Xenoulis PG, Suchodolski JS et al. Identification of three mutations in the pancreatic secretory trypsin inhibitor gene of Miniature Schnauzers. J Vet Intern Med 2007; 21: 614 (abstract).

8. Williams DA, Steiner JM. Canine pancreatic disease. In: Ettinger SJ, Feldman EC (eds.) Textbook of Veterinary Internal Medicine. St. Louis, Elsevier Saunders, 2005; 1482-1488.

9. Hanichen T, Minkus G. Retrospektive Studie zur Pathologie der Erkrankungen des exokrinen Pankreas bei Hund und Katze. Tierdrzt- liche Umschau 1990; 45: 363-368.

10. Steiner JM, Newman SJ, Xenoulis PG et al. Comparison of sensitiv­ity of serum markers in dogs with macroscopic evidence of pan- creatitis.J Vet Intern Med 2007; 21: 614 (abstract).

11. Newman SJ, Steiner JM, Woosley K et al. Localization of pancreatic inflammation and necrosis in dogs. J Vet Intern Med 2004; 18: 488­493.

12. Watson PJ, Roulois AJ, Scase T et al.

13. DeCock HEV, Forman MA, Farver TB et al. Prevalence and his­topathologic characteristics of pancreatitis in cats. Vet Pathol 2007; 44: 39-49.

14. Bradley EL. A clinically based classification system for acute pan­creatitis. Arch Surg 1993; 128: 586-590.

15. Newman SJ, Steiner JM, Woosley K et al. Histologic assessment and grading of the exocrine pancreas in the dog.J Vet Diagn Invest 2006; 18: 115-118.

16. Hess RS, Kass PH, Shofer FS et al. Evaluation of risk factors for fatal acute pancreatitis in dogs. J Am Vet Med Assoc 1999; 214: 46-51.

17. Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis.J Clin Gastroenterol 2003; 36: 54-62.

18. Xenoulis PG, Suchodolski SJ, Swin E et al. Correlation of serum triglyceride and canine pancreatic lipase immunoreactivity (cPLI) concentrations in Miniature Schnauzers. J Vet Intern Med 2006; 20: 750-751 (abstract).

19. DiMagno EP, Chari S. Acute pancreatitis. In: Feldman M, Friedman LS, Sleisenger MH (eds.) Gastrointestinal and liver disease. Philadel­phia, WB Saunders, 2002; 913-941.

20. Matthiesen DT, Mullen HS. Problems and complications associated with endocrine surgery in the dog and cat. Problems in Veterinary Medicine 1990; 2: 627-667.

21. Westermarck E, Saario E. Traumatic pancreatic injury in a cat - a case history. Acta Vet Scand 1989; 30: 359-362.

22. Salisbury SK, Lantz GC, Nelson RW et al. Pancreatic abscess in dogs: Six cases (1978-1986). J Am Vet Med Assoc 1988; 193: 1104­1108.

23. Stimson EL, Espada Y, Moon M et al. Pancreatic abscess in nine dogs. J Vet Intern Med 1998; 9: 202 (abstract).

24. Simpson KW, Shiroma JT, Biller DS et al. Ante mortem diagnosis of pancreatitis in four cats. J Small Anim Pract 1994; 35: 93-99.

25. Dubey JP, Carpenter JL. Histologically confirmed clinical toxoplas­mosis in cats: 100 cases (1952-1990).

26. Rothenbacher H, Lindquist WD. Liver cirrhosis and pancreatitis in a cat infected with Amphimeruspseudofelineus.JAm Vet MedAssoc 1963; 143:1099-1102.

27. Mohr AJ, Lobetti RG,Van der Lugt JJ. Acute pancreatitis: a newly recognised potential complication of canine babesiosis. J S Afr Vet Assoc 2000; 71: 232-239.

28. Frick TW, Speiser DE, Bimmler D et al. Drug-induced acute pan­creatitis: Further criticism. Dig Dis 1993; 11: 113-132.

29. Badalov N, Baradarian R, Iswara K et al. Drug-induced acute pan­creatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007; 5: 648-661.

30. Aste G, Di Tommaso M, Steiner JM et al. Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis. Vet Res Commun 2005; 29 Suppl 2: 269—272.

31. Hill RC, Van Winkle TJ. Acute necrotizing pancreatitis and acute suppurative pancreatitis in the cat. A retrospective study of 40 cases (1976-1989). J Vet Intern Med 1993; 7: 25-33.

32. Simpson KW. Current concepts of the pathogenesis and pathophysi­ology of acute pancreatitis in the dog and cat. Comp Cont Ed Prac Vet 1993;15: 247-253.

33. Norman J. The role of cytokines in the pathogenesis of acute pan­creatitis. Am J Surg 1998; 175: 76-83.

34. Ryan CP, Howard EB. Systemic lipodystrophy associated with pan­creatitis in a cat. Feline Pract 1981; 11: 31-34.

35. Hess RS, Saunders HM, Van Winkle TJ et al. Clinical, clinicopatho- logic, radiographic, and ultrasonographic abnormalities in dogs with fatal acute pancreatitis: 70 cases (1986-1995). J Am Vet Med Assoc 1998; 213: 665-670.

36. Washabau RJ. Acute necrotizing pancreatitis. In: August JR (ed.) Consultations in feline internal medicine. St. Louis, Elsevier Saunders, 2006; 109-119.

37. Suter PF, Olsson SE. Traumatic hemorrhagic pancreatitis in the cat: A report with emphasis on the radiological diagnosis.JAm Vet Radiol Soc 1969; 10: 4-11.

38. Etue SM, Penninck DG, Labato MA et al. Ultrasonography of the normal feline pancreas and associated anatomic landmarks: a prospective study of 20 cats.

39. Lamb CR. Pancreatic edema in dogs with hypoalbuminemia or por­tal hypertension. J Vet Intern Med 1999; 13: 498-500.

40. Saunders HM, VanWinkle TJ, Drobatz K et al. Ultrasonographic findings in cats with clinical, gross pathologic, and histologic evi­dence of acute pancreatic necrosis: 20 cases (1994-2001).JAm Vet Med Assoc 2002; 221: 1724-1730.

41. Forman MA, Marks SL, De Cock HEV et al. Evaluation of serum feline pancreatic lipase immunoreactivity and helical computed to­mography versus conventional testing for the diagnosis of feline pancreatitis. J Vet Intern Med 2004; 18: 807-815.

42. Saunders HM. Ultrasonography of the pancreas. Problems in Veteri­nary Medicine 1991; 3: 583-603.

43. Newman SJ, Steiner JM, Woosley K et al. Correlation of age and incidence of pancreatic exocrine nodular hyperplasia in the dog. Vet Pathol 2005; 42: 510-513.

44. Hecht S, Penninck DG, Keating JH. Imaging findings in pancreatic neoplasia and nodular hyperplasia in 19 cats. Vet Radiol Ultrasound 2007; 48: 45-50.

45. Swift NC, Marks SL, MacLachlan NJ et al. Evaluation of serum fe­line trypsin-like immunoreactivity for the diagnosis of pancreatitis in cats. JAm Vet Med Assoc 2000; 217: 37-42.

46. Gerhardt A, Steiner JM, Williams DA et al. Comparison of the sen­sitivity of different diagnostic tests for pancreatitis in cats. J Vet Intern Med 2001;15:329-333.

47. Turner MA. The role of US and CT in pancreatitis. Gastrointest En­dosc 2002; 56: S241-S245.

48. Spillmann T, Litzlbauer HD, Moritz A et al. Computed tomography and laparoscopy for the diagnosis of pancreatic diseases in dogs. Proc 18^thACVIMForum 2000; 485-487.

49. Jaeger JQ, Mattoon JS, Bateman SW et al. Combined use of ultra­sonography and contrast enhanced computed tomography to evalu­ate acute necrotizing pancreatitis in two dogs. Vet Radiol Ultrasound 2003; 44: 72-79.

50. Mansfield CS, Jones BR. Trypsinogen activation peptide in the diagnosis of canine pancreatitis.

51. Steiner JM, Broussard J, Mansfield CS et al. Serum canine pancreatic lipase immunoreactivity (cPLI) concentrations in dogs with sponta­neous pancreatitis. J Vet Intern Med 2001; 15: 274 (abstract).

52. Steiner JM, Teague SR, Williams DA. Development and analytic validation of an enzyme-linked immunosorbent assay for the meas­urement of canine pancreatic lipase immunoreactivity in serum. Can J Vet Res 2003; 67: 175-182.

53. Steiner JM, Wilson BG, Williams DA. Development and analytical validation of a radioimmunoassay for the measurement of feline pancreatic lipase immunoreactivity in serum. Can J Vet Res 2004; 68: 309-314.

54. Steiner JM, Berridge BR, WojcieszynJ et al. Cellular immunolo­calization of gastric and pancreatic lipase in various tissues obtained from dogs. Am J Vet Res 2002; 63: 722-727.

55. Steiner JM, Rutz GM, Williams DA. Serum lipase activities and pan­creatic lipase immunoreactivity concentrations in dogs with exo­crine pancreatic insufficiency. Am J Vet Res 2006; 67: 84-87.

56. Nathens AB, Curtis JR, Beale RJ et al. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 2004; 32: 2524-2536.

57. Heinrich S, Schafer M, Rousson V et al. Evidence-based treatment of acute pancreatitis - A look at established paradigms. Ann Surg 2006; 243: 154-168.

58. Kingsnorth A, O’Reilly D. Acute pancreatitis. Br Med J 2006; 332: 1072-1076.

59. Freeman LM, Labato MA, Rush JE et al. Nutritional support in pancreatitis: a retrospective study. J Vet Emergency and Critical Care 1995; 5:32-40.

60. Hansen B. Analgesics in cardiac, surgical, and intensive care patients. In: Kirk RW, Bonagura JD (eds.) Current Veterinary Therapy XI. Phila­delphia, WB Saunders, 1992; 82-87.

61. De la Puente-Redondo VA, Tilt N, Rowan TG et al. Efficacy of maropitant for treatment and prevention of emesis caused by intra­venous infusion of cisplatin in dogs. Amer J Vet Res 2007; 68: 48-56.

62. Balldin G, Ohlsson K. Trasylol prevents trypsin-induced shock in dogs. Hoppe-Seylers Z Physiol Chem 1979; 360: 651-656.

63. Satoh H, Harada M, Tashiro S et al. The effect of continuous arterial infusion of gab exate mesilate (F OY-007) on experimental acute pancreatitis. J Med Invest 2004; 51: 186-193.

64. Imrie CW, Benjamin IS, Ferguson JC. A single center double-blind trial ofTrasylol therapy in primary acute pancreatitis. BrJ Surg 1978; 65: 337-341.

65. Kitagawa M, Hayakawa T. Antiproteases in the treatment of acute pancreatitis. JOP 2007; 8: 518-525.

66. Logan JC, Callan MB, Drew K et al. Clinical indications for use of fresh frozen plasma in dogs: 74 dogs (October through December 1999).JAm Vet Med Assoc 2001; 218: 1449-1455.

67. Leese T, Holliday M, Heath D et al. Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. Br J Surg 1987; 74: 907-911.

68. Leese T, Holliday M, Watkins M et al. A multicentre controlled clini­cal trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis. Annals of the Royal College of Surgeons of England 1991; 73: 207-214.

69. Bourgaux JF, Defez C, Muller L et al. Infectious complications, prog­nostic factors and assessment of anti-infectious management of 212 consecutive patients with acute pancreatitis. Gastroent Clin Biol 2007; 31: 431-435.

70. Howes R, Zuidema GD, CameronJL. Evaluation of prophylactic antibiotics in acute pancreatitis. J Surg Res 1975; 18: 197-200.

71. Lankisch PG, Lerch MM. The role of antibiotic prophylaxis in the treatment of acute pancreatitis. J Clin Gastroenterol 2006; 40: 149­155.

72. Isenmann R, Buchler MW, Friess H et al. Antibiotics in acute pan­creatitis. Dig Surg 1996; 13: 365—369.

73. Mazaki T, IshiiY, Takayama T. Meta-analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Br J Surg 2006; 93: 674—684.

74. Dellinger EP, Tellado JM, Soto NE et al. Early antibiotic treatment for severe acute necrotizing pancreatitis — A randomized, double­blind, placebo-controlled study. Ann Surg 2007; 245: 674—683.

75. Zhou YM, Xue ZL, Li YM et al. Antibiotic prophylaxis in patients with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int 2005; 4: 23-27.

76. Johnson CD, Charnley R, Rowlands B et al. UK guidelines for the management of acute pancreatitis. Gut 2005; 54: 1-9.

77. Cook AK, Breitschwerdt EB, Levine JF et al. Risk factors associated with acute pancreatitis in dogs: 101 cases (1985-1990).JAm Vet Med Assoc 1993; 203: 673-679.

78. Pezzilli R, Fantini L. Diagnosis of autoimmune pancreatitis: clinical and histological assessment. JOP 2005; 6: 609-611.

79. Toomey DP, Swan N, Torreggiani W^r et al. Autoimmune pancreatitis. BrJ Surg 2007; 94: 1067-1074.

80. Weiss DJ, Gagne JM, Armstrong PJ. Relationship between inflam­matory hepatic disease and inflammatory bowel disease, pancreatitis, and nephritis in cats.JAm Vet Med Assoc 1996; 209: 111^-1116.

81. Sakai M, Harada K, Matsumura H et al. A case of feline pancreatitis. J Vet Med Sci 2006; 68: 1331-1333.

82. Karanjia ND, Lutrin FJ, Chang Y-B et al. Low dose dopamine pro­tects against hemorrhagic pancreatitis in cats. J Surg Res 1990; 48: 440-443.

83. Sweiry JH, Mann GE. Role of oxidative stress in the pathogenesis of acute pancreatitis. Scand J Gastroenterol 1996; 31: 10-15.

84. Kraft W, Kaimaz A, Kirsch M et al. Behandlung akuter Pankreatiden des Hundes mit Selen. Kleintierpraxis 1995; 40: 35-43.

85. Braganza JM, Scott P, Bilton D et al. Evidence for early oxidative stress in acute pancreatitis. Clues for correction. Inter J Pancreatology 1995; 17: 69-81.

86. Kuklinski B. Akute Pankreatitis - eine “free radical disease”. Leta- Htatssenkung durch Natriumselenit (Na2SeO3) - Therapie. Zeitschrift fur die gesamte Innere Medizin 1992; 47: 165-167.

87. Virlos IT, Mason J, Schofield D et al. Intravenous n-acetylcysteine, ascorbic acid and selenium-based anti-oxidant therapy in severe acute pancreatitis. Scand J Gastroenterol 2003; 38: 1262-1267.

88. McCloy R. Chronic pancreatitis at Manchester, UK - Focus on antioxidant therapy. Digestion 1998; 59: 36-48.

89. McKay CJ, Curran F, Sharples C et al. Prospective placebo-control­led randomized trial of lexipafant in predicted severe acute pancrea­titis. BrJ Surg 1997; 84: 1239-1243.

90. Kingsnorth AN, Galloway SW, Formela LJ. Randomized, double­blind phase II trial of lexipafant, a platelet-activating factor antago­nist, in human acute pancreatitis. BrJ Surg 1995; 82: 1414-1420.

91. Abu-Zidan FM, Winsor JA. Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials. Eur J Surg 2002; 168: 215­219.

92. Hartwig W, Werner J, Muller CA et al. Surgical management of se­vere pancreatitis including sterile necrosis. J Hepatobiliary Pancreat Surg 2002; 9: 429-435.

93. Buchler MW, Gloor B, Muller CA et al. Acute necrotizing pancrea­titis: Treatment strategy according to the status of infection. Ann Surg 2000; 232: 619-626.

94. Ruaux CG, Atwell RB. A severity score for spontaneous canine acute pancreatitis. Aust Vet J 1998; 76: 804-808.

95. Dominguez-Munoz JE. Early prognostic evaluation of acute pan­creatitis: why and how should severity be predicted. In: Dominguez- Munoz JE (ed.) Clinical pancreatology for practicing gastroenterologists and surgeons. Malden, Blackwell Publishing, 2005; 47-55.

96. Khwannimit B. A comparison of three organ dysfunction scores: MODS, SOFA and LOD for predicting ICU mortality in critically ill patients. J Med Assoc Thai 2007; 90: 1074-1081.

97. Banks PA. Medical management of acute pancreatitis and compli­cations. In: Go VLW, DiMagno EP, Gardner JD et al. (eds.) The pancreas: biology, pathobiology and disease. New York, Raven Press, 1993;593-613.

98. Kimmel SE, Washabau RJ, Drobatz KJ. Incidence and prognostic value of low plasma ionized calcium concentration in cats with acute pancreatitis : 46 cases (1996-1998). JAm Vet Med Assoc 2001; 219: 1105-1109.

99. Figarella C, De Caro A, Leupold D et al. Congenital pancreatic lipase deficiency. J Pediatr 1980; 96: 412-416.

100. Xenoulis PG, Fradkin JM, Rapp SW et al. Suspected isolated pan­creatic lipase deficiency in a dog. J Vet Intern Med 2007; 21: 1113­1116.

101. Fox JN, Mosley JG, Vogler GA et al. Pancreatic function in domes­tic cats with pancreatic fluke infection. J Am Vet Med Assoc 1981; 178: 58-60.

102. Proschowsky HF, Fredholm M. Exocrine pancreatic insufficiency in the Eurasian dog breed - inheritance and exclusion of two can­didate genes. Anim Genet 2007; 38: 171-173.

103. Moeller EM, Steiner JM, Clark LA et al. Inheritance of pancreatic acinar atrophy in German Shepherd dogs. Am J Vet Res 2002; 63: 1429-1434.

104. Wiberg ME, Saari SAM, Westermarck E. Exocrine pancreatic at­rophy in German Shepherd dogs and Rough-coated Collies: An end result of lymphocytic pancreatitis. Vet Pathol 1999; 36: 530­541.

105. Westermarck E, Batt RM,Vaillant C et al. Sequential study of pan­creatic structure and function during development of pancreatic acinar atrophy in a German Shepherd Dog. Am J Vet Res 1993; 54: 1088-1094.

106. Westermarck E, Wiberg M, Steiner JM et al. Exocrine pancreatic insufficiency in dogs and cats. In: Ettinger SJ, Feldman EC (eds.) Textbook of Veterinary Internal Medicine. St. Louis, Elsevier Saunders, 2005; 1492-1495.

107. DiMagno EP, Go VLW, Summerskill WHJ. Relations between pan­creatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973; 288: 813-815.

108. Batchelor DJ, Noble PJ, Taylor RH et al. Prognostic factors in ca­nine exocrine pancreatic insufficiency: prolonged survival is likely if clinical remission is achieved. J Vet Intern Med 2007; 21: 54-60.

109. Steiner JM, Williams DA. Serum feline trypsin-like immunoreac­tivity in cats with exocrine pancreatic insufficiency.J Vet Intern Med 2000; 14: 627-629.

110. Wiberg ME, Westermarck E. Subclinical exocrine pancreatic in­sufficiency in dogs. JAm Vet Med Assoc 2002; 220: 1183-1187.

111. Westermarck E, Wiberg M. Exocrine pancreatic insufficiency in dogs. Vet Clin North Am Small Anim Pract 2003; 33: 1165­1179.

112. Williams DA, Reed SD. Comparison of methods for assay of fecal proteolytic activity. Vet Clin Path 1990; 19: 20-24.

113. Williams DA, Batt RM. Sensitivity and specificity of radioimmu­noassay of serum trypsin-like immunoreactivity for the diagnosis of canine exocrine pancreatic insufficiency. J Am Vet Med Assoc 1988; 192: 195-201.

114. Spillmann T, Wittker A, Teigelkamp S et al. An immunoassay for canine pancreatic elastase 1 as an indicator for exocrine pancreatic insufficiency in dogs. J Vet Diagn Invest 2001; 13: 468-474.

115. Spillmann T, Eigenbrodt E, Sziegoleit A. Die Bestimmung und kli- nische Relevanz der fakalen pankreatischen Elastase beim Hund. Tierdrztliche Praxis 1998; 26: 364-368.

116. Steiner JM, Pantchev N. False positive results of measurement of fecal elastase concentration for the diagnosis of exocrine pancreatic insufficiency in dogs.J Vet Intern Med 2006; 20: 751 (abstract).

117. Steiner JM, Rehfeld JF, Pantchev N. Serum CCK concentrations in dogs with severely decreased fecal elastase concentrations. J Vet Intern Med 2006; 20: 1520 (abstract).

118. Wiberg ME, Lautala HM, Westermarck E. Response to long-term enzyme replacement treatment in dogs with exocrine pancreatic insufficiency. JAm Vet Med Assoc 1998; 213: 86-90.

119. Westermarck E. Treatment of pancreatic degenerative atrophy with raw pancreas homogenate and various enzyme preparations. J Vet Med A 1987; 34:728-733.

120. Pidgeon G, Strombeck DR. Evaluation of treatment for pancreatic exocrine insufficiency in dogs with ligated pancreatic ducts. Am J Vet Res 1982; 43: 461-464.

121. Somogyi L, Toskes PP. Conventional pancreatic enzymes are more efficient than enteric-coated enzymes in delivering trypsin to the duodenum of chronic pancreatitis patients. Gastroenterol. 1998; 114: A500 (abstract).

122. Marvola M, Heinamaki J, Westermarck E et al. The fate of single­unit enteric-coated drug products in the stomach of the dog. Acta Pharm Fenn 1986; 95: 59-70.

123. Rutz GM, Steiner JM, Williams DA. Oral bleeding associated with pancreatic enzyme supplementation in three dogs with exocrine pancreatic insufficiency. J Am Vet Med Assoc 2002; 221: 1716­1718.

124. Perry LA, Williams DA, Pidgeon G et al. Exocrine pancreatic in­sufficiency with associated coagulopathy in a cat. J Am Anim Hosp Assoc 1991; 27: 109-114.

125. Rutz GM, Steiner JM, Bauer JE et al. Effects of exchange of dietary medium chain triglycerides for long-chain triglycerides on serum biochemical variables and subjectively assessed well-being of dogs with exocrine pancreatic insufficiency. Am J Vet Res 2004; 65: 1293-1302.

126. Westermarck E, Junttila J, Wiberg M. The role of low dietary fat in the treatment of dogs with exocrine pancreatic insufficiency. Am J Vet Res 1995; 56: 600-605.

127. Westermarck E, Myllys V, Aho M. Intestinal bacterial overgrowth in dogs with exocrine pancreatic insufficiency: Effect of enzyme replacement and antibiotic therapy. J Vet Intern Med 1991; 5: 131 (abstract).

128. DiMagno EP. Medical treatment of pancreatic insufficiency. Mayo Clin Proc 1979; 54: 435-442.

129. Proesmans M, De Boeck K. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes. Eur J Pediatr 2003; 162: 760­763.

130. Lockhart AC, Rothenberg ML, Berlin JD. Treatment for pancreatic cancer: Current therapy and continued progress. Gastroenterology 2005; 128: 1642-1654.

131. Andrews LK. Tumors of the exocrine pancreas. In: Holzworth J (ed.) Diseases of the cat. Philadelphia, WB Saunders, 1987; 505­507.

132. Munster M, Reusch C. Tumoren des exokrinen Pankreas der Katze. Tierdrztl Prax 1988; 16: 317-320.

133. Larsson MHMA, Dagli MLZ, Xavier JG et al. Obstructive jaundice caused by a metastatic adenocarcinoma of the pancreas in a cat. Ars Veterinaria 1989; 5: 113-116.

134. Brown PJ, Mason KV, Merrett DJ et al. Multifocal necrotising ste- atitis associated with pancreatic carcinoma in three dogs. J Small Anim Pract 1994; 35: 129-132.

135. Brooks DG, Campbell KL, Dennis JS et al. Pancreatic paraneoplas­tic alopecia in three cats.J Am Anim HospAssoc 1994; 30: 557-563.

136. Godfrey DR. A case of feline paraneoplastic alopecia with second­ary Malassezia-associated dermatitis. J Small Anim Pract 1998; 39: 394-396.

137. Bennett PF, Hahn KA, Toal RL et al. Ultrasonographic and cy- topathological diagnosis of exocrine pancreatic carcinoma in the dog and cat. JAm Anim Hosp Assoc 2001; 37: 466-473.

138. Zenoble RD, Crowell WA, Rowland GN. Adenocarcinoma and hypercalcemia in a dog. Vet Pathol 1979; 16: 122-123.

139. Lamb CR, Simpson KW, Boswood A et al. Ultrasonography of pancreatic neoplasia in the dog: A retrospective review of 16 cases. Vet Rec 1995; 137: 65-68.

140. Seaman RL. Exocrine pancreatic neoplasia in the cat: A case series. J Am Anim Hosp Assoc 2004; 40: 238-245.

141. Eloy R, Bouchet P, Clendinnen G et al. New technique of total pancreatectomy without duodenectomy in the dog. Am J Surg 1980; 140: 409-412.

142. Withrow SJ. Exocrine cancer of the pancreas. In: Withrow SJ, MacEwen EG (eds.) Small Animal Clinical Oncology. Philadelphia, WB Saunders, 2001; 321-323.

143. VanEnkevort BA, O'Brien RT, Young KM. Pancreatic pseudocysts in 4 dogs and 2 cats: Ultrasonographic and clinicopathologic find­ings. J Vet Intern Med 1999; 13: 309-313.

144. Hines BL, Salisbury SK, Jakovljevic S et al. Pancreatic pseudocyst associated with chronic-active necrotizing pancreatitis in a cat. J Am Anim Hosp Assoc 1996; 32: 147-152.

145. Coleman M, Robson M. Pancreatic masses following pancreatitis: Pancreatic pseudocysts, necrosis, and abscesses. Compend Contin Educ Pract Vet 2005; 27: 147-154.

146. Ephgrave K, Hunt JL. Presentation of pancreatic pseudocysts: im­plications for timing of surgical intervention. Am J Surg 1986; 151: 749-753.

147. SheldonWG. Pancreatic flukes (Eurytrema procyonis) in domestic cats.J Am Vet Med Assoc 1966; 148: 251-253.

148. Roudebush P, Schmidt DA. Fenbendazole for treatment of pancre­atic fluke infection in a cat. J Am Vet Med Assoc 1982; 180: 545­546.

149. Lewis DT, Malone JB, Taboada J et al. Cholangiohepatitis and choledochectasia associated with Amphimeruspseudofelineus in a cat. J Am Anim Hosp Assoc 1991; 27: 156-161.

150. Boyden EA. The problem of the pancreatic bladder. Am J Anat 1925; 36: 151-183.

151. Bailiff NL, Norris CR, Seguin B et al. Pancreatolithiasis and pan­creatic pseudobladder associated with pancreatitis in a cat. J Am Anim Hosp Assoc 2004; 40: 69-74.

152. Jubb KVF. The Pancreas. In: Jubb KVF, Kennedy PC, Palmer N (eds.) Pathology of Domestic Animals. San Diego, Academic Press Inc., 1993; 407-424.

9